Just how radical is the FDA's complete response letter move?
The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
Technology’s role in supplying healthcare professionals with...
Insight on what HCPs need from the pharmaceutical industry to improve access to reliable, trusted medicines information.
On nuclear medicine and oncology, SHINE technologies
Greg Piefer, founder and CEO of SHINE Technologies, discusses nuclear medicine and the role of radiopharmaceuticals in oncology.
New Evidation CEO to double down on patient data empowerment
pharmaphorum spoke with Leslie Olay Wilberforce, Evidation's new CEO, about the company's unique approach to real-world data and her future plans.
Featured Content
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Immune Cell Engager Partnering & Investment Summit
Driving high ROI across immune cell engagers through strategic partnerships & investments, capitalizing on novel targets & asset tunability...
2nd ADC & Novel Conjugates Partnering & Investment Summit
Refine your strategy, sharpen your positioning, and meet the right partners - all at the most efficient networking event of the ADCconference calendar
2nd Autoimmunity & Inflammation Partnering & Investment Summ...
Driving deal-making across targeted cell depletion, checkpoint agonism, tolerance, and oral anti-inflammatory biologics...
Welcome to the 2nd Raw Materials for Cell & Gene Therapy Sum...
Streamline Supply Chain Communications to Optimize Phase Appropriate QC Testing, Comparability & GMP Manufacturing of Raw Materials...
Network With EHS Professionals - EHS&S for Biopharma West
Advancing Biosafety & Sustainability in R&D & Manufacturing